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Received 16 September 2004; received in revised form 15 March 2006; accepted 15 March 2006AbstractPhospholipases are critical for modiﬁcation and redistribution of lipid substrates, membrane remodeling and
microbial virulence. Among the many different classes of phospholipases, fungal phospholipase B (Plb) proteins show
the broadest range of substrate speciﬁcity and hydrolytic activity, hydrolyzing acyl ester bonds in phospholipids and
lysophospholipids and further catalyzing lysophospholipase–transacylase reactions. The genome of the opportunistic
fungal pathogen Candida albicans encodes a PLB multigene family with ﬁve putative members; we present the ﬁrst
characterization of this group of potential virulence determinants. CaPLB5, the third member of this multigene family
characterized herein is a putative secretory protein with a predicted GPI-anchor attachment site. Real-time RT-PCR
gene expression analysis of CaPLB5 and the additional CaPLB gene family members revealed that ﬁlamentous growth
and physiologically relevant environmental conditions are associated with increased PLB gene activity. The
phenotypes expressed by null mutant and revertant strains of CaPLB5 indicate that this lipid hydrolase plays an
important role for cell-associated phospholipase A2 activity and in vivo organ colonization.
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Phospholipases play a central role in cellular pro-
cesses such as signal transduction and inﬂammation
through their effect on the metabolism of phospholipids
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further contribute to pathogenesis and virulence
through the release or breakdown of bioactive com-
pounds which affect host cell function (Ghannoum,
2000; Schmiel and Miller, 1999; Songer, 1997; Titball,
1993). Substrates for phospholipases are either phos-
pholipids or lysophospholipids, comprised of a polar
head group (e.g. ethanolamine, choline, inositol, or
serine esteriﬁed to phosphoric acid) and one or two non-
polar fatty acyl chains esteriﬁed to a glycerol backbone.
The substrate speciﬁcity of phospholipases is determined
both by the phospho-headgroups and the chain length
and saturation of the fatty acyl side chains. Some
phospholipases have broader substrate speciﬁcities than
others. Phospholipases A1 and A2 hydrolyze the ester
bonds at the sn-1 and sn-2 positions of the glycerol
moiety, respectively, yielding free fatty acids and 2-acyl
or 1-acyl lysophospholipids. The two phosphodiester
bonds found in the polar headgroup of the amphipathic
phospholipid are cleaved by phospholipase C (ﬁrst
bond), which releases the phospho-head group, and
phospholipase D (second bond) which releases only the
head group. Phospholipase B (Plb) enzymes possess
hydrolytic activities that release both fatty acids from a
phospholipid or the remaining fatty acid from a
lysophospholipid (lysophospholipase). Additionally, ly-
sophospholipase–transacylase activity is associated with
some Plb enzymes allowing these to transfer a free fatty
acid to a lysophospholipid and hence produce a
phospholipid. Hydrolase and acyltransferase activities
have been detected in several fungi including Saccha-
romyces cerevisiae, Candida albicans, Penicillium chry-
sogenum, and Cryptococcus neoformans (Chen et al.,
1997; Lee et al., 1994; Mirbod et al., 1995; Saito et al.,
1991; Witt et al., 1984).
C. albicans, the most important fungal opportunistic
pathogen (Edmond et al., 1999; Odds, 1988), harbors
several phospholipase genes, including genes for phos-
pholipases C and D as well as a gene family with
homology to Plb proteins (see Table 1). Although the
distinction between phospholipase A, Plb and lysophos-
pholipases is difﬁcult, clear sequence homologs of
mammalian or bacterial phospholipase A1 and A2 genesTable 1. The PLB gene family in the genome sequence of Candida
Gene and reference Haploid a
ORF(s)
CaPLB1 (Hoover et al., 1998; Leidich et al., 1998) 6.3690
CaPLB2 (Sugiyama et al., 1999) 6.1985
CaPLB3 (continuous allele, this work) 6.795–6.79
CaPLB4 6.6206
CaPLB5 (this work) 6.4037, 6.6
Direct sequencing of the region between the discontinuous ORFs of CaPLB3
continuous CaPLB3 allele (see text). ORF 6.6348 is an NH2-terminal fragmen
index.html, http://www.candidagenome.org/ and references Braun et al., 200seem to be lacking from the genomic repertoire of C.
albicans. Two Plb genes, CaPLB1 and CaPLB2, have
been studied in detail (Hoover et al., 1998; Leidich et al.,
1998; Mukherjee et al., 2001; Sugiyama et al., 1999);
both encode putative secreted proteins with typical
signal sequences, but only CaPLB1 has been clearly
implicated in virulence. Abrogation of CaPlb1 activity
by gene inactivation renders the mutant strain-less
virulent in experimental animal models (Leidich et al.,
1998; Mukherjee et al., 2001). Attack of host cell
membranes during tissue invasion and facilitation of
adhesion processes through interaction with host-cell
phospholipids (Prakobphol et al., 1994, 1997) could be
crucial roles for Plb enzymes in pathogenesis of C.
albicans.
In this study, we report the characterization of a third
member of the PLB gene family of C. albicans, CaPLB5,
so designated due to its phylogenetic relationships (see
below) with the other phospholipases. Gene expression
analysis of the CaPLB gene family using relative
quantitations by real-time RT-PCR revealed differential
expression proﬁles with increased CaPLB gene expres-
sion under conditions promoting hyphal or pseudohy-
phal growth. Direct sequencing and sequence analysis of
single CaPLB5 alleles revealed the presence of two
different alleles in several strains of this pathogen.
Targeted gene disruption of both alleles in a wild-type
strain of C. albicans results in reduced phospholipase A2
(PLA2) activity in vitro and attenuated virulence as
measured by host tissue colonization in a mouse model
of systemic infection. Reintroduction of an intact gene
copy into the null strain at the original locus results in
intermediate levels of organ tissue burden when
compared to the wild type and the null mutant.Materials and methods
Microorganisms, plasmids, and culture media
The C. albicans strains used in this work are listed in
Table 2. C. albicans strain SS is a clinical isolate
provided by Dr. Remo Morelli (San Francisco Statealbicans
ssembly 6 Diploid assembly 19 allele(s)
19.689/19.8307
19.690/19.8309
6 19.1442–19.1443/19.9017–19.9018
19.6594
348 19.5102/19.12568
encoding NH2- and COOH-terminal portions of the protein revealed a
t of ORF 6.4037 (see also www-sequence.stanford.edu/group/candida/
5; Jones et al., 2004).
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Table 2. Genotypes of C. albicans strains used in this study
Strain Parent and genotype Source or reference
SS Clinical isolate Miyasaki et al. (1994)
SC5314 Wild-type strain Gillum et al. (1984)
CAI4 SC5314; ura3D::limm434/ura3D::limm434 Fonzi and Irwin (1993)
ATCC 44808 Wild-type strain isolated from human blood Manning and Mitchell (1980)
KH44 ATCC 44808; plb5LKD::FRT-FLP-MPAR-FRT/PLB5SN This work
KH44-13 KH44; plb5LKD::FRT/PLB5SN This work
KH44-90 KH44-13; plb5LKD::FRT/plb5SND::FRT-FLP-MPAR-FRT This work
KH44-91 KH44-90; plb5LKD::FRT/plb5SND::FRT This work
KH44-KI KH44-91; plb5LKD::FRT/PLB5LK-FRT-FLP-MPAR-FRT This work
KH44-KL KH44-KI; plb5LKD::FRT/PLB5LK-FRT This work
S. Theiss et al. / International Journal of Medical Microbiology 296 (2006) 405–420 407University, San Francisco, CA, USA). The Ura
auxotrophic strain C. albicans CAI4 was provided by
Dr. W. Fonzi (Department of Microbiology and
Immunology, Georgetown University Medicine Center,
Washington, DC, USA). The wild-type strain C.
albicans ATCC 44808 was used for gene disruptions
(see below). C. albicans cells were propagated on YPD
agar plates (10 g yeast extract, 20 g peptone, 20 g
glucose, 15 g agar per liter) or YPD medium at 30 1C.
Lee’s medium was used to grow C. albicans in yeast or
ﬁlamentous forms (Lee et al., 1975). Host for subcloning
and sequencing in pBluescript was Escherichia coli
DH5a. For screening of the genomic library of C.
albicans in Lambda FixII (Stratagene, La Jolla, CA,
USA) E. coli XL1-Blue MRA (P2) was used. Bacteria
were grown at 37 1C in Luria–Bertani (LB) medium with
suitable supplements.Cloning and sequencing of CaPLB5
Mapping and sequencing of a 10-kb PstI–PstI
genomic DNA fragment, encoding almost the entire
ABC transporter gene MLT1 (Theiss et al., 2002),
revealed an incomplete ORF with high similarity to
fungal phospholipases. The entire coding region of the
putative PLB gene CaPLB5 was isolated from a C.
albicans fosmid library (kindly provided by Dr. S.
Scherer) using probes derived from the known sequences
of the phospholipase and MLT1, respectively. Fosmid
clone 9d6 was further sequenced by primer walking.
Using the oligonucleotide primers AMPLI1 (for oligo-
nucleotide sequences, see Table 3) and AMPLI3 the
entire CaPLB5 gene with 1 kb 50-ﬂanking region and
0.4 kb 30-ﬂanking region was PCR ampliﬁed from
several C. albicans strains and sequenced with the
dideoxy sequencing method using a Thermo Sequenase
Fluorescent Labeled Primer Cycle Sequencing Kit
(Amersham Pharmacia Biotech) and a LI-COR DNA
Sequencer 4000 (Lincoln, NE, USA). The nucleotide
sequence of CaPLB5 was submitted to GenBank under
the accession number AF038128.Nucleic acid isolation and hybridization
Genomic DNA for cloning and Southern hybridiza-
tions was isolated from C. albicans as described
previously (Millon et al., 1994). Southern hybridizations
were carried out with non-radioactive probes using the
ECL labeling and detection kit (Amersham Pharmacia
Biotech, Freiburg, Germany). A PCR fragment gener-
ated with primer pair AMPLI1/PLB1390 was used as
probe for CaPLB5 hybridizations. Total RNA for
Northern hybridizations was isolated with the hot acid
phenol method (Ausubel et al., 1989). Membrane-bound
RNA was stained with methylene blue before hybridiza-
tion to check rRNA bands for equal loading. Hybridi-
zations were carried out using standard protocols.
Messenger RNA mapping
The start points of CaPLB5 transcription were
determined by 50-RACE (Ausubel et al., 1989). Follow-
ing reverse transcription with Superscript II (Stratagene)
of total RNA with the CaPLB5-speciﬁc primer UP-
PLIP3, a poly-A tail was added to the ﬁrst strand by
terminal deoxynucleotide transferase action. Subse-
quently, the 50-end of the CaPLB5 cDNA was ampliﬁed
with the anchor primer DTNOT and the nested primer
ECOMUPL5. PCR fragments were cloned in pBlue-
script after digestion with NotI and EcoRI, and four
clones were sequenced. The polyadenylation sites of
CaPLB5mRNA were identiﬁed by 30-RACE: Following
the isolation of poly-A+ RNA from total RNA using a
Oligotex mRNA Mini Kit (Qiagen, Hilden, Germany)
the RNAs were reverse transcribed using primer
DTNOT. The 30-end of the CaPLB5 cDNA was
ampliﬁed with primers RACE3/DTNOT, subsequently
cloned and sequenced.
Targeted disruption of the C. albicans CaPLB5 gene
Sequence-tagged disruption cassettes consisting of the
dominant selection marker MPAR (Ko¨hler et al., 1997,
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Table 3. DNA oligonucleotides used in this study
Oligonucleotide 50-sequence-30
AMPLI1 TAGTCAAGCTTCGCCATTACAAAGAGC
AMPLI3 CTACTAAGCTTTTCCACTGGTGCATC
AMPLI6 CTACTACTAGTGTCGACGTTTTCCACTGGTGCATC
DTNOT AATTCGCGGCCGCTTTTTTTTTTTTTTTT
ECOMUPL3 TAGTCGAATTCTTGCTGAGATAG
NOTTAG TAATTGCGGCCGCTGCAGNWNNSNCTCAGTAACAGATACTTG
P3_1340 TATCGTGCCATGCTTAATGG
P3_2305 CCAATCCCGCCATCTATAAC
PLB1390 GACTGCTCGAGTGTAGAACTTGCTGAATCG
RACE3 CAGATGTAAGTGACGAGG
UPPLIP3 TCCACCACTGAATGACAACC
XNTAG CAGGGACGACTGCTCGAGNRNNRNTGTAGAACTTGCTGAATCG
PLB1-A GATGAATGGGCAGCATGTGTT
PLB1-B GGCTCACCCTTATAGATGGTACCA
PLB1-D GCATCTCTTACATTGTTCTGTCTGTTC
PLB1-E (Probe) TCTTTCTTGCTCTCTCCGTATGATGGCG
PLB2-A AGGTGAAGACGGTCAGAATGTTC
PLB2-B GCTGATCCATCTGGCCAATT
PLB2-C ATGTTCCCTTGCTTCCATTGA
PLB2-D TGTTTTTATCTGCCGATTGATCA
PLB2-E (Probe) CCACCGTAAGGTAAGCGCAATCTTTGC
PLB3-A AAGAAAGACGTGGTATTGAACAACTG
PLB3-B TGCTTCCATTAGTTAAACTTGAATCAG
PLB3-C TGGTATTGAACAACTGGATCAATGT
PLB3-E (Probe) AAGTACCATCCCAACAATAATT
PLB4-A TCGCTTATGATAATTCGGCTGATA
PLB4-B CCACATCAGGTACATATGGGAAACT
PLB4-C TGCCTCCATGGTAGCATCATAC
PLB4-E (Probe) ATTTGGGAATCAAAGTAATGG
PLB5-A CGCTGCCTCTGTCTCTAGTGTTAG
PLB5-B GATGATCCGGTAGTGGTACTGGTT
PLB5-C CTTGCAGCTAAAACCCACACAA
PLB5-D GATCCGGTAGTGGTACTGGTTTG
PLB5-E (Probe) TGGCGGTACATCTTCCACGACCCA
Restriction enzyme sites are underlined and sequence tags are in bold. Oligonucleotides for nested and semi-nested real-time PCR are italicized.
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recombinase caFLP (Staib et al., 1999; Wirsching et al.,
2000) and CaPLB5-speciﬁc ﬂanking regions were con-
structed for gene disruption (see Fig. 4). Initially, a PCR
fragment generated with primers AMPLI1 and AMPLI3
from genomic DNA of strain ATCC 44808 was cut with
HindIII at the site introduced by AMPLI1 and with
BamHI at an internal site in CaPLB5. This fragment
was cloned in pSKK (pBluescript SK with the KpnI site
removed) to yield pKP1. Removal of the NotI and XhoI
sites in pKP1 resulted in pKPNX25. The product of the
divergent PCR of pKPNX25 with the primers XNTAG
and NOTTAG was cut with XhoI and NotI and
subsequently ligated to the XhoI–NotI fragment of
pSFI1 (Wirsching et al., 2000) harboring the MPAR
ﬂipper. Following transformation in E. coli, bacterial
clones carrying plasmids were pooled, their bar-codedplasmids were isolated (pDIS-Pool) and digested with
ApaI/SacI to yield the linear disruption constructs. Gel-
puriﬁed DNA fragments were used for transformation
of C. albicans ATCC 44808 by electroporation as
described previously (Ko¨hler et al., 1997). Transfor-
mants were plated on SC medium (6.7 g YNB, 0.77 g
Complete Supplement Mixture (Bio 101), 20 g glucose,
and 15 g agar per liter) containing 10 mg/ml mycophe-
nolic acid (MPA; Sigma-Aldrich). Positive clones were
screened for correct integration of the disruption
cassette by PCR and Southern hybridization. Excision
of the MPAR ﬂipper necessary for sequential disruption
of both CaPLB5 alleles was carried out as described
previously (Morschha¨user et al., 2005; Wirsching et al.,
2000). Amplicons spanning the tagged integration sites
of homozygous disruption mutants were generated and
sequenced directly. For conﬁrmation of the expected
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four sequence tags ﬂanking the integration sites had to
be different.
Reintegration of CaPLB5 in a caplb5 null mutant
For complementation of the caplb5/caplb5 null
mutation, an insertion construct with an intact CaPLB5
gene copy was generated. For this purpose, a PCR
amplicon harboring the CaPLB5 gene and its promoter/
terminator regions was generated with primers AMPLI1
and AMPLI6 and subsequently digested with SpeI/
HindIII. This fragment was ligated to the SpeI–HindIII
plasmid backbone of a derivative of pKPNX25 without
the SalI site in the multiple cloning site, thereby
substituting the insertion cloned in pKPNX25 (see
above) with a functional CaPLB5 gene plus ﬂanking
regions. The resulting plasmid was named p4486. The
XhoI–SacII fragment of one disruption plasmid of
pDIS-Pool comprised of the MPAR-ﬂipper and a 30-
fragment of CaPLB5 was inserted in p4486 that had
been digested with SalI/SacII (the SalI site was
introduced by primer AMPLI6), resulting in pPIKOM.
The ApaI–SacI fragment of pPIKOM containing the
CaPLB5-MPAR–Flip-30-Dcaplb5 construct was used for
transformation of the null mutant C. albicans KH44-91.
Transformants were screened by PCR for reintegration
of CaPLB5 at one of the disrupted loci. One transfor-
mant (KH44-KI) was chosen for MPAR ﬂipper removal
and the resulting MPA-sensitive strain KH44-KL was
used as the CaPLB5 complementation control.
Growth characteristics of caplb5 mutants in culture
Growth of mutated strains was compared to wild-type
growth in liquid media and agar plates of YPD, SC,
RPMI 1640, Lee’s media and 10% fetal calf serum at 25,
30 and 37 1C. Growth and ﬁlamentation was also tested
on Synthetic Low Ammonium Dextrose (SLAD; (Csank
et al., 1998)) agar plates following incubation at 37 1C
for 7 days. Furthermore, Sabouraud Dextrose Agar,
YPD and Lee’s pH 6.8 media plates were also
supplemented with 10% egg yolk to detect secretion of
lipolytic compounds around colonies. Growth in the
presence of lysophosphatidylcholine (Lyso-PC; Sigma-
Aldrich) or lysophosphatidylinositol (Lyso-PI; Avanti
Polar Lipids, Alabaster, AL) was determined by OD600
measurement after 24 and 48 h incubation of cultures in
5-ml glass tubes at 30 1C.
Determination of PLA2 activity
PLA2 assays were performed as described earlier
(Chaitidis et al., 1998). Brieﬂy, 25 mM of 1-palmitoyl-2-
arachidonoyl phosphatidylcholine (PAPC) was soni-cated for 1min in assay medium containing 10mM
Tris–HCl, pH 8.0, 150mM NaCl and 5mM CaCl2.
Following preincubation for 5min, the reaction was
started with 50 mg of cell lysate from the wild-type C.
albicans strain ATCC 44808 or the CaPLB5 mutants,
which were grown in Sabouraud glucose broth contain-
ing 1% peptone medium for 36 h at 37 1C. After a
reaction time of 15min lipids were extracted from the
mixture by the Bligh and Dyer method (Bligh and Dyer,
1959). Liberation of arachidonic acid (AA) was mea-
sured by reverse-phase HPLC on a Nucleosil-100-7 C18
column (Macherey-Nagel, Germany) with a precolumn
5-C18-AB using a solvent system with methanol:water:-
acetic acid (85:15:0.01, v/v) at a ﬂow rate of 1ml/min.
Detection was performed with a Diode Array Detector
(Shimadzu, Japan). Peaks eluted at about 11.8min
represented AA and were quantitated by peak area
using a calibration curve with authentic cPLA2, sPLA2,
and iPLA2 standards.Systemic infection model with CaPLB5 mutants
Balb/c mice were infected via the tail vein with 0.4ml
of a 0.9% NaCl solution containing 4 105 cells of
either the wild-type strain C. albicans ATCC 44808, the
heterozygous caplb5/CaPLB5 mutant KH44-13, the
null mutant KH44-91 or the complemented strain
KH44-KL. Mice were sacriﬁced after 3 days post
inoculation, and colony-forming units (CFU) of C.
albicans were determined after homogenization of
isolated organs.Multiplex real-time RT-PCR expression analysis
Strain ATCC 44808 was grown to stationary phase in
Lee’s medium pH 6.8 at 25 1C, washed two times,
subsequently inoculated in fresh Lee’s medium pH 4.5
and 6.8, respectively. Cultures were incubated in a
rotary shaker at 25 or 37 1C for 3 and 48 h. Total RNA
was isolated using glass bead disruption and TRIZOL
reagent (Invitrogen, Carlsbad, CA, USA). Following
DNase I treatment total RNA was further puriﬁed with
RNeasy (Qiagen). The RT nested or semi-nested real-
time PCR was carried out as previously described
(Dolganov et al., 2001) with few modiﬁcations. A 10-
ng aliquot of DNase-treated total C. albicans RNA was
reverse transcribed using SuperScriptIII First-Strand
Synthesis System (Invitrogen) and oligo (dT)20 primers.
One-tenth of the cDNA was pre-ampliﬁed using the
Advantage 2 Polymerase Mix (BD Biosciences Clon-
tech, Palo Alto, CA, USA) with a mixture of the
respective outer primers A and B (see Table 3). The
multiplexed PCR reactions were performed with one
cycle at 94 1C for 1min; 25 cycles at 94 1C for 15 s, 55 1C
for 15 s, 70 1C for 15 s; and one cycle at 70 1C for 5min
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South San Francisco, CA, USA). For the real-time PCR
reactions, 3 ml of 1:60 diluted pre-ampliﬁcation material
was added to a total 10-ml real-time PCR mix containing
QuantiProbe PCR Master Mix (Qiagen, Valencia, CA,
USA), a 6-FAM and BHQ-1 labeled probe (primer E),
inner primers C and D for CaPLB2 and CaPLB5 genes
or primers C and B for CaPLB3 and CaPLB4 genes.
For CaPLB1 the primer combination was A, D, and E.
The real-time PCR reactions were performed with one
cycle at 50 1C for 2min; one cycle at 95 1C for 10min;
and 40 cycles at 95 1C for 15 s and 60 1C for 1min in
an ABI 7900HT Sequence Detection System (Applied
Biosystems, Foster City, CA, USA). All the primers
and probes were designed using Primer Express
software (Applied Biosystems) and were synthesized
by Biosearch Technologies (Novato, CA, USA).
The cycle at which the ampliﬁcation product signal
reached a threshold (the threshold cycle, CT value)
was analyzed using SDS2.1 software following
the manufacturer’s instructions (Applied Biosystems).
The threshold was chosen within the geometric (ex-
ponential) phase of the ampliﬁcation curve. To choose a
robustly expressed control gene, the CT values of 90
genes obtained from cells grown at seven different
growth conditions were compared using the GeNorm
software (www.wzw.tum.de/gene-quantiﬁcation/). EFB1
was stably expressed in this analysis and was used for
data normalization. An average CT value was obtained
from the three data sets and normalized to the average
CT value of EFB1. For relative quantitation of gene
expression, the comparative CT method was used
(Applied Biosystems, 2001) and relative expression was
determined as 2DDCT.Results
The CaPLB5 gene from C. albicans: sequence,
annotation and characterization
CaPLB5, isolated as described in Materials and
methods, lies in close proximity to a 50-ORF with
deduced amino acid sequence similarity to phosphomu-
tases (CaPMU5, allelic orfs 19.5103 and 19.12569 inFig. 1. Gene organization at the CaPLB5-MLT1 locus and prima
CaPLB5 locus with the adjacent genes CaCCR4 and MLT1 as wel
sequence of one allele of CaPLB5 in C. albicans ATCC 44808 and its
genes CaPMU5 and CaCCR4 are boxed in the promoter and ter
promoter region are underlined. Transcription start sites are marked
marked by a downward arrow. The sequence region deleted in the
Amino acids KR as possible Kex2p processing sites are indicated by
hydrophobic COOH-terminal with a putative o cleavage site are dou
CaPlb5 is in bold italics. Non-silent allelic differences to the second a
gray shading. Highly conserved active-site regions in the protein seqAssembly 19 of the C. albicans genome sequence) and a
30 ORF 6.4036 (19.5101 and 19.12567) that is located
downstream of CaPLB5 on the opposite DNA strand
encoding a candidal homolog of the S. cerevisiae CCR4
gene (see Fig. 1A).
CaPLB5 shows the highest deduced amino acid
sequence identity in databank searches with known
fungal type B phospholipases (lysophospholipases);
these include C. albicans CaPlb1 (identity 46%; Hoover
et al., 1998; Leidich et al., 1998; Mukherjee et al., 2001)
and CaPlb2 (47%; Sugiyama et al., 1999) and enzymes
from S. cerevisiae (ScPlb1 46%, ScPlb2 47%, ScPlb3
48% (Lee et al., 1994; Merkel et al., 1999)) or P.
chrysogenum Plb1 (42%; Masuda et al., 1991). Pfam
searches also reveal a lysophospholipase catalytic
domain (Accession number: PF01735; from amino acids
177–670; Fig. 1B) within CaPlb5 which is found in other
Plb enzymes and cytoplasmic PLA2.
TBlastn analysis of the C. albicans genome Assembly
19 (http://www-sequence.stanford.edu/group/candida/)
with the CaPlb5 sequence revealed additional ORFs
with a high degree of homology to this protein and to
the other fungal Plbs (see Table 1): The protein encoded
by orf19.6594 (only one allele in Assembly 19) shares
52% identity and is the most closely related protein to
CaPlb5; this gene has been annotated as CaPLB4 by the
C. albicans Genome Annotation Consortium (Braun et
al., 2005). ORFs 19.1442/9017 and 19.1443/9018 are
adjacent to each other on contigs 10119/20119 of the
recent Assembly 19 of the C. albicans genome. Accord-
ing to their sequence similarities, they could encode the
NH2-terminal and COOH-terminal portion of a ﬁfth
Plb, which we denote CaPlb3 due to its closer
phylogenetic relationship with CaPlb1 and CaPlb2 (see
below). Since the short region separating these ORFs
does not harbor canonical splice sites for an intron, we
resequenced the region to check whether CaPLB3 is
likely to be a pseudogene. A PCR product was
generated from genomic DNA of C. albicans SC5314
using the primer pair P3_1340-P3_2305 and sequenced
directly. The region between the ORFs showed no
sequence ambiguities indicative of allelic differences,
however, in comparison to Assembly 19 the TAA stop
codon of ORFs 19.1442/9017 was replaced by TTA
encoding leucine and a cytidine residue at position 24 ofry structure of CaPLB5: (A) schematic representation of the
l as the partial ORFs CaPMU5 and CaNTG1. (B) Nucleotide
deduced amino acid sequence. The stop codons of the adjacent
minator region, respectively. Putative TATA elements in the
by an upward arrow, a polyadenylation site in the terminator is
gene disruption (see Fig. 4) is underlined with a undulate line.
deltas (DD). The putative NH2-terminal signal peptide and the
ble underlined. The NH2-terminal serine-rich region unique to
llele in ATCC 44808 and to both SC5314 alleles are marked by
uence are boxed.
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Fig. 1. (Continued)
S. Theiss et al. / International Journal of Medical Microbiology 296 (2006) 405–420412ORFs 19.1443/9018 was deleted leading to a frameshift
that renders the respective allelic CaPLB3 ORFs
continuous. For the following studies we used the
deduced amino acid sequence of the corrected CaPLB3
gene.
An amino acid alignment of CaPlb5 and other fungal
Plbs was carried out with CLUSTALX (Version 1.8)
with default parameters and then manually corrected
(data not shown). CaPlb5 shares conserved sequences
reported to be essential for phospholipase activity
(Ghannoum, 2000) with each of these proteins
(boxed in Fig. 1B: SGGGYRAM, GLSGG and
DGGEDLQN). The arginine, serine and aspartate
residues in bold might constitute the active center triad
of these enzymes. Due to an NH2-terminal extension
that includes a serine-rich domain (amino acids 25–91)
the deduced protein sequence of CaPlb5 is 754 amino
acids in length, resulting in a theoretical Mr of 81,373
and considerably larger than most other known fungal
Plbs. Among the completed fungal genome sequences a
similar NH2-terminal extension is only found in a
putative Plb of the hemiascomycetous yeast Debaryo-
myces hansenii (Dujon et al., 2004). The aligned Plb
protein sequences were used to construct a phylogenetic
tree with the maximum parsimony algorithm in PAUP-
SEARCH of the Wisconsin Package (Version 10.3;
Accelrys Inc., San Diego, CA, USA). As shown in
Fig. 2, candidal Plbs appear to form two subclusters
together with three D. hansenii proteins in this phylo-
genetic tree, one cluster including CaPlb1, CaPlb2,
CaPlb3 and a single D. hansenii orthologue, the other
cluster the enzymes CaPlb4 and CaPlb5, each with a
respective D. hansenii orthologue. Overall, the phyloge-netic tree constructed with fungal Plbs correlates well
with trees derived from other phylogenetic markers (e.g.
rDNA; Diezmann et al., 2004). Nodes marking the
Hemiascomycetes (yeasts), Euascomycetes (Aspergilli,
etc.), Archiascomycetes (Schizosaccharomyces pombe),
and Basidiomycetes (Cryptococcus and Ustilago) clearly
can be found.
Mapping of the CaPLB5 transcript provides evidence
that the translational start is likely to be the ATG
designated as position 1 (Fig. 1B). Start sites of
transcription were localized by 50-RACE to positions
137 and 90, thereby conﬁrming the ATG at position
1 as the ﬁrst start codon in the CaPLB5 mRNA and
concomitantly the NH2-terminal extension of CaPlb5.
Putative TATA elements for promoter activity are
marked in Fig. 1B. Using 30-RACE, a polyadenylation
site was identiﬁed at position 2300, 39 bp from the end
of the CaPLB5 coding sequence.
A putative signal peptide with a cleavage site at amino
acid 19 was detected at the NH2-terminus of CaPlb5 by
SIGNALP (Nielsen et al., 1997). Presence of an NH2-
terminal signal peptide as well as a COOH-terminal
stretch of hydrophobic amino acids suggest that CaPlb5
contains a GPI-anchor at the processed COOH-termi-
nus (see Fig. 1B). The asparagine at position 726 was
identiﬁed as a potential cleavage site o for the COOH-
terminal GPI-attachment signal peptide using the Big-PI
Fungal Predictor (Eisenhaber et al., 2004) for modiﬁca-
tion site prediction. Analysis of the other Plbs in C.
albicans revealed potential GPI-anchor sites in CaPlb3
and CaPlb4 (data not shown). De Groot et al. (2003)
recently used another algorithm to identify fungal GPI
proteins and also denoted the three CaPlbs as GPI
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Fig. 2. CaPlb5 and other fungal Plbs. The unrooted phyloge-
netic tree was generated using the maximum parsimony
algorithm in PAUPSEARCH/PAUPDISPLAY of the GCG
package with aligned Plb sequences. Organism and Plb
(accession number in parentheses): Aspergillus fumigatus,
AfPlb1 (AAQ85122), AfPlb2 (AAQ85123); A. nidulans,
AnPlb1 (EAA64795), AnPlb2 (BAD95522); C. albicans,
CaPlb1 (AAC61890), CaPlb2 (BAA36162), CaPlb3
(orf19.1442/3; the continuous amino acid sequence deduced
from direct sequencing of the junction between the adjacent
ORFs was used), CaPlb4 (orf19.6594), CaPlb5 (AAF08980);
C. glabrata, CgPlb1 (AAM16160), CgPlb2 (AAM19335),
CgPlb3 (CAG58709); Cryptococcus bacillisporus, CrbPlb1
(CAC83081); Cr. neoformans, CnPlb1 (AAF65220), CnPlb2
(AAF61964); Debaryomyces hansenii, DhPlb1 (CAG88860),
DhPlb2 (CAG87754), DhPlb3 (CAG90378); Gibberella zeae,
GzPlb1 (EAA69595), GzPlb2 (EAA70315), GzPlb3
(EAA73343); Kluyveromyces lactis, KlPlb1 (BAA28619);
Magnaporthe grisea, MgPlb1 (EAA56932); Neurospora crassa,
NcPlb1 (AAC03052), NcPlb2 (CAE76554); Penicillium chry-
sogenum, PcPlb1 (P39457); Pichia jadinii, PjPlb1 (BAC79383);
S. cerevisiae, ScPlb1 (NP_013721), ScPlb2 (NP_013719),
ScPlb3 (NP_014632); Schizosaccharomyces pombe, SpPlb1
(NP_593194), SpPlb2 (CAB94277), SpPlb3 (CAB40176),
SpPlb4 (CAB57433), SpPlb5 (CAB16354); Torulaspora del-
brueckii, TdPlb1 (BAA06860); Ustilago maydis, UmPlb1
(EAK81777), and Yarrowia lipolytica, YlPlb1 (CAG79599).
CaPlb family members are depicted in bold.
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sites. Another study only predicted CaPlb5 to be GPI
anchored (Lee et al., 2003).Heterozygosity of CaPLB5 alleles
Direct sequencing of PCR products derived from the
CaPLB5 region in the homozygous strains C. albicans
CAI4 and ATCC 44808 revealed nucleic acid sequence
ambiguities at several positions (for details see Fig. 1B).
For corroboration of these sequence variations we
sequenced the single intact alleles in heterozygous caplb5
mutants. At least two distinct CaPLB5 alleles exist in
each of the C. albicans strains CAI4 and 44808 with
sequence variations in the gene coding sequences.
Surprisingly, apart from silent mutations (data not
shown) the alleles differ even in their amino acid
sequence since at two positions in the CaPLB5 gene a
non-silent C/T transition and a G/T transversion lead to
the substitution of leucine to serine (amino acid position
57) and lysine to asparagine (amino acid position 208),
respectively. Therefore, we designated one allele as
L57K208 and the other as S57N208. Fig. 1B compares the
sequence of the S57N208 allele of strain ATCC 44808
with the L57K208 allele in the protein sequence. BLAST
analysis (Altschul et al., 1990) of the recent Assembly 19
of the Candida Genome Sequencing Project (http://
www-sequence.stanford.edu/group/candida/search.html)
reveals that the same allelic differences in the protein
sequences are also present in the CaPLB5 alleles (ORFs
19.5102/12568) of the sequenced strain C. albicans
SC5314 that is the parent strain to CAI4 (Fonzi and
Irwin, 1993). Besides a few silent mutations in the
nucleic acid sequences (data not shown), there is only
one additional amino acid exchange at position 709
between the pairs of allelic sequences of ATCC 44808
and SC5314 (see Fig. 1B). Comparison of the other
CaPlb protein sequences in Assembly 19 reveals the
presence of further allelic sequence differences in CaPlb1
(D577N; ORFs 19.689/8307) and the NH2-terminal
fragment of CaPlb3 (S346L; ORFs 19.1442/9017).CaPLB5 expression analysis
CaPLB5 mRNA expression during growth in YPD
medium at 30 1C was monitored from logarithmic to
stationary phase by Northern hybridization using total
RNAs isolated at various times in the growth cycle (4, 6,
8, 10, 12, 14, 16, and 24 h). The transcript was detected
throughout the time course, however, its level increased
about three-fold within the 4–10-h period of logarithmic
phase and then remained constant from late-log phase
to 24 h (data not shown). To address whether CaPLB5
mRNA is regulated during the transition from yeast to
hyphal cells, we isolated total RNA from C. albicans
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S. Theiss et al. / International Journal of Medical Microbiology 296 (2006) 405–420414freshly inoculated from overnight cultures and grown
for 3 h in Lee’s media (Lee et al., 1975) favoring either
growth of yeast forms (pH 4.5, 25 1C) or germ tubes (pH
6.8, 37 1C). Cells were also incubated at intermediate
conditions of pH 6.8, 25 1C and pH 4.5, 37 1C. While
cells grew in the yeast form at 25 1C, they showed
substantial pseudohyphal growth at pH 4.5, 37 1C. The
highest levels of CaPLB5 mRNA after 3 h incubation as
determined by real-time RT-PCR were found in RNA
isolated from the germ tubes grown at 37 1C, pH 6.8,
while the lowest levels were found in cells grown at 25 1C
(see Fig. 3). The other CaPLBs showed the highest
expression at pH 4.5, 37 1C, especially CaPLB1 with 66-
fold induction. After prolonged incubation in the media
for 48 h, expression levels for all CaPLBs increased to a
large extent, in particular under conditions with low pH
(4.5) and elevated temperature (37 1C; see Fig. 3).
Overall, CaPLB expression patterns became very
similar. CaPLB1, CaPLB2 and CaPLB3 transcript
levels are very low at 3 h in 25 1C, which explains the
high induction levels, e.g. at 48 h, 37 1C, pH 4.5.
Northern hybridization results (data not shown) corro-
borate these results since CaPLB1–CaPLB3 mRNAs
were not detectable in RNA isolated at 3 h, 25 1C.166
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CaPLB4Generation of CaPLB5 mutants
A caplb5/caplb5 null mutant of the wild-type strain C.
albicans ATCC 44808 was generated by sequential
targeted gene disruption using the dominant MPAR
resistance gene in conjunction with the inducible caFLP
recombinase system for marker excision (MPAR ﬂipper;
Wirsching et al., 2000). The heterozygous caplb5LK/
CaPLB5SN mutant C. albicans KH44-13 was used in a
second round of disruption to inactivate the remaining
intact CaPLB5 allele ﬁnally yielding, after marker
excision, the homozygous mutant KH44-91. Fig. 4
shows the disruption strategy and veriﬁcation byFig. 3. Relative quantitation of CaPLB1, CaPLB2, CaPLB3,
CaPLB4 and CaPLB5 expression in Lee’s medium. C. albicans
ATCC 44808 cells were grown under the indicated pH and
temperatures to promote yeast (pH 4.5 or 6.8 at 25 1C), hyphal
growth (pH 6.8, 37 1C) or mixed growth with predominantly
pseudohyphae (pH 4.5, 37 1C) and total RNA was isolated
after 3 and 48 h of growth. Two-step multiplex real-time RT-
PCR was performed to determine the relative expression
(2DDCT) of the CaPLB genes. Expression levels of the stably
expressed EFB1 gene were used for normalization as described
in the Materials and methods section. Expression levels were
calibrated to the respective CaPLB level in Lee’s medium pH
4.5 at 25 1C, 3 h. Average values and ranges (error bars) of
relative expression in triplicate quantitations are shown. The
predominant morphotypes for the respective growth condi-
tions are indicated: yeast (Y), pseudohyphae (Ph), germ tubes
(Gt), and hyphae (H).Southern hybridization of genomic DNA. The disrup-
tion cassettes included short random sequence tags
ﬂanking the FRT sites of the MPAR ﬂipper construct
which could be used to exclude mitotic recombination or
chromosome loss as the cause for caplb5 homozygosity1 2 5 3 4 12
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Fig. 4. CaPLB5 disruption and reintegration: (A) schematic diagram of a CaPLB5 disruption cassette with random sequence tags
depicted as ‘‘N’’ (not drawn to scale, tags omitted from subsequent diagrams). Two cassettes with different tags were used
sequentially to inactivate the CaPLB5 gene. Heterozygosity of the tags present on both alleles could be easily detected by direct
sequencing of PCR products across the integration site. Using theMPAR ﬂipper strategy, each integration step was followed by FLP
recombinase-mediated excision of the dominant MPAR marker leaving only a FRT (shown as black triangle) sequence ﬂanked by
tags. (B) Construct used for reintegration of an intact CaPLB5 allele in the caplb5/caplb5 mutant KH44-91. (C) Southern
hybridization analysis of genomic DNA (ScaI digest) isolated from the wild type ATCC 44808, the heterozygous mutants KH44 and
KH44-13, the null mutants KH44-90 and KH44-91 as well as strain KH44-KL with a reconstituted CaPLB5 allele. Diagrams of the
hybridization fragments are shown on the right. Additionally, Northern hybridization results of total RNAs isolated from the
aforementioned strains are shown. The null mutants showed no CaPLB5 expression, the heterozygous strains and the
complemented strain showed reduced levels of expression when compared to the wild type. Methylene blue staining of membrane-
bound rRNAs served as loading control. The location of the probe used in Northern and Southern hybridizations is indicated with a
black line. B (BamHI), K (KpnI), P (PstI), Sc (ScaI).
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methods). The 638-bp deletion in each CaPLB5 allele
comprised two out of three conserved domains report-
edly essential for phospholipase activity (see above and
Fig. 1) and resulted in loss of full-length CaPLB5
mRNA expression in the null mutants as documented by
Northern analysis (Fig. 4). The heterozygous caplb5LK/
CaPLB5SN mutants KH44 and KH44-13 showed
similarly reduced CaPLB5 transcript levels when com-
pared to the wild-type expression. We chose to delete
only a portion of the 2262-bp coding sequence because
of close proximity of the CaCCR4 gene (see Fig. 1).
For veriﬁcation that the null mutant phenotype was
not due to ectopic effects generated during the
transformation procedure, a complemented strain with
a reintegrated intact CaPLB5LK allele was constructed
from KH44-91 using the MPAR ﬂipper cassette shown
in Fig. 4B. Correct integration of the CaPLB5LK-MPAR
ﬂipper cassette in strain KH44-KI was veriﬁed by PCR,
and the subsequent marker excision resulted in strainKH44-KL, a CaPLB5LK-FRT/caplb5LKD::FRT hetero-
zygote that had regained intermediate expression of
CaPLB5, similar to the expression level seen in KH44
and KH44-13 (see Fig. 4).Phenotypic characterization of CaPLB5 mutants
Growth of wild-type C. albicans ATCC 44808, the
caplb5 mutants and the reconstituted strain KH44-KL
was compared in several media (YPD, Lee’s, Spider
medium, 10% serum, and synthetic low ammonium
dextrose, SLAD; Csank et al., 1998) and no differences
in growth rate and morphology were observed. C.
albicans ATCC 44808 consistently formed the largest
precipitation zones around colonies on egg yolk agar
(see Materials and methods) of all C. albicans strains
tested (SC5314, CAI4, SS). This could indicate higher
secreted lipolytic activities of ATCC 44808, however,
we could detect no differences in precipitation zone
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Fig. 5. Organ colonization in a systemic mouse model with the
mutant strains in comparison with the wild type. CFUs of
infected organs were determined in four mice for each strain.
ANOVA and Dunnett error protection was used to calculate
statistical signiﬁcance of differences in organ colonization:
CFUs of the caplb5 null mutant KH44-91 are signiﬁcantly
reduced compared with wild-type ATCC 44808 CFUs in the
liver and the left kidney (marked by an asterisk).
S. Theiss et al. / International Journal of Medical Microbiology 296 (2006) 405–420416formation between this wild-type strain and its isogenic
caplb5 mutants on different media with egg yolk.
Growth assays with addition of lyso-PC (0.1, 1,
10mM) and lyso-PI (0.01–0.5mM), both possible
substrates for CaPlb5, revealed in comparison to the
wild-type strain no altered susceptibility of the caplb5
null mutant to these compounds. However, release of
AA from 1-palmitoyl-2-arachidonoyl phosphatidylcho-
line (PAPC), as measured in a PLA2 assay of cell lysates,
dropped below detection levels in the caplb5 null
mutant, while the heterozygous mutant and the CaPLB5
complemented strain retained approximately half of the
activity of the wild type (see Table 4). Thus the CaPLB5
alleles encode a signiﬁcant portion of cell-bound PLA2
activity in C. albicans.
To determine whether, similar to CaPlb1 (Ghannoum,
2000; Ibrahim et al., 1995; Mirbod et al., 1995;
Mukherjee et al., 2001), CaPlb5 as a putative phospho-
lipase is involved in virulence, we compared the organ
colonization of caplb5 mutants to the wild type in a
mouse systemic infection model. Disruption of the
CaPLB5 gene led to an attenuated virulence phenotype
of the caplb5 null mutant strain KH44-91 of intrave-
nously infected Balb/c mice. Using ANOVA and Dunett
error protection CFUs in the liver and the left kidney of
strain KH44-91 were identiﬁed as signiﬁcantly reduced
when compared to infection with the wild-type strain
ATCC 44808, while in the brain as well as in the right
kidney CFU reduction was statistically not signiﬁcant
(Fig. 5). The heterozygous mutant KH44-13 with a wild-
type CaPLB5SN allele and the reconstituted strain
KH44-KL with a single intact copy of CaPLB5LK
showed intermediate levels of CFU. Homozygous
caplb5 null mutants generated in the ura-negative strain
CAI4 using the URA3-blaster technique (Fonzi and
Irwin, 1993) showed similar attenuation of organ
colonization in vivo (referenced to the ura3/URA3
parent C. albicans CAF2-1; data not shown). However,
reported difﬁculties in interpretation of virulence studies
that could be encountered with an auxotrophic strainTable 4. Release of arachidonic acid from 1-palmitoyl-2-
arachidonoyl phosphatidylcholine (PAPC) by C. albicans
lysates
Source of enzymatic activity Arachidonic acid liberation
from PAPC (mM/min)
cPLA2 (0.25 IU) 2.470.3 (5)
ATCC 44808 1.170.2 (3)
KH44-13 0.5570.1 (3)
KH44-91 o0.01 (3)
KH44-KL 0.7370.24 (3)
The values of arachidonic acid liberation represent the mean7SD of
the indicated number of experiments (denoted in parentheses).
Cytosolic PLA2 (cPLA2) was used as control. Experimental conditions
are described in Materials and methods.(Chen et al., 2004; Garcia et al., 2001), led us to
abandon the URA3-blaster strategy and instead use the
above described MPAR ﬂipper method in a wild-type
strain.Discussion
Upstream sequences of the MLT1 gene (Theiss et al.,
2002) in C. albicans revealed the presence of a third
phospholipase gene in this fungus with high amino acid
homology to the other known fungal phospholipases B/
lysophospholipases. Two additional putative lysophos-
pholipase genes were identiﬁed in a TnBLAST survey of
the C. albicans genome sequence. Therefore, in contrast
to three phosholipase B genes in non-pathogenic S.
cerevisiae and D. hansenii, C. albicans harbors a gene
family of ﬁve members encoding these enzymes.
Our real-time PCR analysis of CaPLB expression in
Lee’s medium revealed that all CaPLB genes are up-
regulated in conditions favoring ﬁlamentous growth, i.e.
pseudohyphae and hyphae formation at elevated tem-
perature (37 1C) and pH 4.5 and 6.8, respectively.
Moreover, CaPLB gene expression levels were increased
in stationary phase. In fact, using Northern or DNA
microarray hybridization CaPLB1, CaPLB2 and
CaPLB3 transcripts were only detectable during later
stages of growth (late logarithmic or stationary phases).
Interestingly, the highest expression levels of CaPLBs in
our study were reached in stationary phase at the
physiologically relevant temperature of 37 1C and an
acidic pH of 4.5 which is similar to the vaginal pH in
ARTICLE IN PRESS
S. Theiss et al. / International Journal of Medical Microbiology 296 (2006) 405–420 417humans. Involvement of gene regulation for ﬁlamentous
growth in CaPLB gene expression has been shown in
recent studies, for example, CaPLB1 is derepressed in
null mutants of the repressor CaTUP1 (Hoover et al.,
1998; Kadosh and Johnson, 2005). CaSsn6, another
regulator of cell morphology appears to exert control on
CaPLB3 gene expression since this phospholipase gene
is up-regulated in cassn6 mutants (Garcia-Sanchez et al.,
2005). The role of other transcription factors in CaPLB
gene expression remains to be elucidated. A recent study
on the inﬂuence of environmental factors like pH and
carbohydrate source on in vitro expression of CaPLB1
revealed a complex pattern of expression in rich media
and chemically deﬁned media supplemented with serum
or phospholipids (Mukherjee et al., 2003). Our quanti-
tative RT-PCR study of CaPLB1 expression adds to this
complexity since we identiﬁed a condition in which
CaPLB1 is in fact strongly induced in chemically deﬁned
medium (Lee’s medium pH 4.5, 37 1C) independent of
supplementation. In vivo expression has been demon-
strated for CaPLB1 and CaPLB2 by RT-PCR in mice
(Schoﬁeld et al., 2005) and CaPlb1 by immunological
detection in host tissue (Mukherjee et al., 2001). We
attempted to analyze the in vivo patterns of CaPLB5
expression using the In vivo Expression Technology
(IVET) adapted to C. albicans (Staib et al., 1999),
however, the high basal level activity of the CaPLB5
promoter led to considerable induction of the FLP
recombinase when grown in culture, thus precluding the
use of this technology without further adaptation to
genes with higher basal expression levels (Bentink and
Ko¨hler; unpublished observations).
All the CaPLB genes identiﬁed in C. albicans are
predicted to contain putative signal sequences by
SignalP (Nielsen et al., 1997), hence the encoded
hydrolytic enzymes are probably secreted under appro-
priate conditions. The Plbs in C. albicans with a
hydrophobic COOH-terminus and a high probability
for a GPI modiﬁcation are CaPlb5, CaPlb3 and CaPlb4.
Thus, these proteins could be localized to the plasma
membrane and/or cell wall, similar to the GPI-modiﬁed
CnPlb1 protein in Cr. neoformans (Djordjevic et al.,
2005). Shedding of cell-associated Plbs as suggested for
CnPlb1 by glucanase, protease or PI-PLC/PLD activ-
ities might also be possible in C. albicans.
The serine-rich region following the signal peptide in
CaPlb5 and the putative orthologue in D. hansenii
appears to be absent in phylogenetically more distant
fungi. We conducted a preliminary survey of
currently available genome sequences of other Candida
species and found that, e.g. C. dubliniensis (http://
www.sanger.ac.uk/Projects/C_dubliniensis/) and C.
tropicalis (http://www.broad.mit.edu/annotation/fungi/
candida_tropicalis/) also harbor a CaPlb5 ortho-
logue with an extended NH2-terminus while more
distantly related C. guillermondi (http://www.broad.mit.edu/annotation/fungi/candida_guilliermondii/) and
C. lusitaniae (http://www.broad.mit.edu/annotation/
fungi/candida_lusitaniae/) seem to lack it. This stretch
of amino acids offers a high density of possible O-
glycosylation and phosphorylation sites, however, its
biological role is unclear. Interestingly, two Kex2
proteinase cleavage sites are located adjacent to the
COOH-terminus of this region (position 138 and 153)
indicating a potential prepropeptide conﬁguration for
processing of CaPlb5. One potential cleavage site is
present in the D. hansenii orthologue. Newport et al.
(2003) recently conducted a survey of putative Kex2
substrates in the C. albicans genome and identiﬁed
several (potentially) secreted hydrolases like secreted
aspartyl proteases and sphingomyelinases with Kex2
sites. CaPlb5 probably failed to be recognized by the
search algorithm employed in this study, because of too
restrictive search parameters. Whether CaPlb5 is indeed
processed by the Kex2 proteinase or other processing
enzymes remains to be elucidated.
Intrastrain heterozygosity in two amino acid residues
of the two alleles present in each of the three C. albicans
strains tested (ATCC 44808, CAI4 and SC5314)
suggests that these exchanges might be of biological
importance. CAI4 is derived from SC5314, but ATCC
44808 has a very different CARE2 hybridization pattern
of genomic DNA (our unpublished observations) and
therefore is likely to be only distantly related to SC5314.
We are currently investigating whether the encoded
allozymes are functionally different and differentially
expressed in vitro or during infection. A survey of
further C. albicans strains will help to judge the
signiﬁcance of these allelic differences and resolve
whether the two amino acid substitutions are compen-
satory or unrelated. Differential in vivo expression of
the two SAP2 alleles in CAI4 which contain two
conserved amino acid exchanges and differ in penta-
meric repeat structures of their promoter regions, has
recently been demonstrated (Staib et al., 2002).
As other similar fungal Plb enzymes, CaPlb5 could be
bifunctional with a lysophospholipase–transacylase ac-
tivity in addition to the hydrolase activity that removes
sn-1 and sn-2 fatty acids from phospholipids and
lysophospholipids. Thus, CaPlb5 and other CaPlbs
under different growth conditions may account for the
phospholipase A activities reported in early studies on
C. albicans phospholipases (reviewed in Ghannoum,
2000). While its range of biochemical activities and
substrates still has to be determined, our ﬁndings on AA
release from PAPC by a putative PLA2 activity of
CaPlb5 pose an intriguing question about the functional
role of this enzyme in pathogenesis. Breakdown of host
cell membranes could not only lead to cell lysis, but also
to the generation of bioactive lipid mediators derived
from host membrane components like AA. Hydrolysis
of host phospholipids and release of free fatty acids may
ARTICLE IN PRESS
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compounds, e.g. eicosanoids such as prostaglandins,
leukotrienes and lipoxins that might play an important
role in pathogenesis (Noverr et al., 2003; Serhan, 2002).
Secreted phospholipases have been recognized as
important virulence factors in microbial infections
including candidiasis (Ghannoum, 2000). A CaPLB1
null mutant showed attenuated virulence in murine
models of hematogenously disseminated candidiasis and
oral-intragastric infection (Leidich et al., 1998; Mukher-
jee et al., 2001). CaPlb5 or the other additional members
of the CaPlb family could account for the residual Plb
activity and virulence in caplb1 mutants. Cell-associated
enzymes may be especially important while Candida is in
close contact with host cells, e.g. during invasion.
However, many environmental and cell biological
factors (morphology) are likely to determine the
temporal and spatial expression and secretion of the
different Plbs in vivo. The composition of host cell
membranes could inﬂuence Plb expression in the fungi;
therefore the caplb5 mutation might be more detri-
mental in liver than in other organs, resulting in the
most signiﬁcant attenuation in this organ. Ultimately,
further functional characterization and in vivo expres-
sion analyses will discern the individual roles of Plb
family members in candidal virulence.Acknowledgements
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